You are here

  • Home
  • Archive
  • Volume 10, Issue 3
  • Accuracy and consequences of using trial-of-antibiotics for TB diagnosis (ACT-TB study): protocol for a randomised controlled clinical trial

Article info

Article menu

Download PDFPDF

XML
Infectious diseases
Protocol
Accuracy and consequences of using trial-of-antibiotics for TB diagnosis (ACT-TB study): protocol for a randomised controlled clinical trial

Authors

  • Titus Henry Divala TB Centre, London School of Hygiene and Tropical Medicine, London, UKHelse Nord Tuberculosis Initiative, University of Malawi College of Medicine, Blantyre, MalawiMalawi-Liverpool Wellcome Trust Clinical Research Programme, University of Malawi College of Medicine, Blantyre, Malawi PubMed articlesGoogle scholar articles
  • Katherine L Fielding TB Centre, London School of Hygiene and Tropical Medicine, London, UKSchool of Public Health, University of the Witwatersrand, Johannesburg-Braamfontein, Gauteng, South Africa PubMed articlesGoogle scholar articles
  • Derek J Sloan School of Medicine, University of Saint Andrews, Saint Andrews, Fife, UK PubMed articlesGoogle scholar articles
  • Neil French Institute of Infection and Global Health, University of Liverpool Faculty of Health and Life Sciences, Liverpool, UK PubMed articlesGoogle scholar articles
  • Marriott Nliwasa TB Centre, London School of Hygiene and Tropical Medicine, London, UKHelse Nord Tuberculosis Initiative, University of Malawi College of Medicine, Blantyre, Malawi PubMed articlesGoogle scholar articles
  • Peter MacPherson Malawi-Liverpool Wellcome Trust Clinical Research Programme, University of Malawi College of Medicine, Blantyre, MalawiClinical Sciences, Liverpool School of Tropical Medicine, Liverpool, UK PubMed articlesGoogle scholar articles
  • Chikondi Charity Kandulu Helse Nord Tuberculosis Initiative, University of Malawi College of Medicine, Blantyre, MalawiMalawi-Liverpool Wellcome Trust Clinical Research Programme, University of Malawi College of Medicine, Blantyre, Malawi PubMed articlesGoogle scholar articles
  • Lingstone Chiume Helse Nord Tuberculosis Initiative, University of Malawi College of Medicine, Blantyre, MalawiMalawi-Liverpool Wellcome Trust Clinical Research Programme, University of Malawi College of Medicine, Blantyre, Malawi PubMed articlesGoogle scholar articles
  • Sanderson Chilanga Helse Nord Tuberculosis Initiative, University of Malawi College of Medicine, Blantyre, MalawiMalawi-Liverpool Wellcome Trust Clinical Research Programme, University of Malawi College of Medicine, Blantyre, Malawi PubMed articlesGoogle scholar articles
  • Masiye John Ndaferankhande Malawi-Liverpool Wellcome Trust Clinical Research Programme, University of Malawi College of Medicine, Blantyre, Malawi PubMed articlesGoogle scholar articles
  • Elizabeth L Corbett TB Centre, London School of Hygiene and Tropical Medicine, London, UKHelse Nord Tuberculosis Initiative, University of Malawi College of Medicine, Blantyre, MalawiMalawi-Liverpool Wellcome Trust Clinical Research Programme, University of Malawi College of Medicine, Blantyre, Malawi PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Titus Henry Divala; titus.divala{at}lshtm.ac.uk
View Full Text

Citation

Divala TH, Fielding KL, Sloan DJ, et al
Accuracy and consequences of using trial-of-antibiotics for TB diagnosis (ACT-TB study): protocol for a randomised controlled clinical trial
BMJ Open 2020;10:e033999. doi: 10.1136/bmjopen-2019-033999

Publication history

  • Received September 1, 2019
  • Revised February 20, 2020
  • Accepted February 27, 2020
  • First published March 25, 2020.
Online issue publication 
March 25, 2020
Previous versions
Review history

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.